In contrast, a recently published study has shown that a C-reactive protein decline could be more rapidly achieved if empirical antibiotic therapy was effective against the microorganism that was subsequently identified as responsible for the VAP episode [25]. This evidence concerns the gene CRP and ventilator-associated pneumonia.